Search results
Repertoire pivot pays dividends with Bristol Myers deal
BioPharma Dive via Yahoo Finance· 21 hours agoThe alliance validates the new direction pursued by Repertoire, a startup that cut staff and...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 7 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 4 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 3 days agoEarnings per share fell 6.1% but topped forecasts by a nickel, according to FactSet. Earnings took...
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
The Wall Street Journal· 4 days agoBristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now...
Large study finds children with skin diseases suffer stigma, bullying and depression
Medical Xpress· 5 days agoThe majority of children and teens with chronic skin diseases such as acne, eczema, psoriasis,...
Gout in Elbow Symptoms
Verywell Health via Yahoo News· 7 days agoPeople assigned male at birth—especially those between ages 30 and 45—and those assigned female at birth who are between ages 55 and 70 are at an...
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales Climb
Investopedia· 7 days agoNovartis beat first-quarter forecasts for profit and sales on rising demand for its blockbuster...
How To Manage Itchy Scalp While Wearing Braids | Essence
Essence· 4 days agoItchy scalp while wearing braids and wigs is an unresolved issue in the Black community. On our...
Novartis lifts guidance after first-quarter results beat expectations
CNBC· 7 days agoIt has previously predicted that adjusted operating income would increase by a "high single-digit"...